Correspondence | Published:

Time to drop the phenylephrine from the paediatric cycloplegia protocol: informing practice through audit

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Farhood Q. Cycloplegic refraction in children with cyclopentolate versus atropine. J Clin Exp Ophthalmol. 2012;3:239.

  2. 2.

    Ebri A, Kuper H, Wedner S. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Invest Ophthalmol Vis Sci. 2007;48:1025–31.

  3. 3.

    Celebi S, Aykan U. The comparison of cyclopentolate and atropine in patients with refractive accommodative esotropia by means of retinoscopy, autorefractometry and biometric lens thickness. Acta Ophthalmol Scand. 1999;77:426–9.

  4. 4.

    Zurevinsky J, Sawchuk K, Lim HJ, Lee CH, Rubab S. A clinical randomized trial comparing the cycloplegic effect of cyclopentolate drops applied to closed eyelids versus open eyelids. Am Orthopt J. 2016;66:114–21.

Download references

Acknowledgements

This work was supported by the National Institute for Health Research (NIHR) Moorfields Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

Author information

Conflict of interest

The authors declare that they have no conflict of interest.

Correspondence to Annegret Dahlmann-Noor.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark
Fig. 1